Matthias Müllner | CEO
bespark*bio
Matthias graduated from the University of Vienna in the field of virology and molecular biology. In 2011 he joined Themis Bioscience, a biotech start-up specialized in the development of vaccines against emerging infectious diseases. At Themis he established the Technical Operations Department and led the group for over a decade as part of the executive management team. In early 2023, Matthias co-founded bespark*bio to continue his passion for developing sophisticated manufacturing processes for viral vector-based medicines.
Appearances:
Day 1 - Tuesday 14th October @ 11:30
Working Group 3: Making Vaccines Real: Aligning Science, Capital, and Supply Chains for Global Impact
This high-level discussion focuses on how to translate great science into usable vaccines - on time and at scale. With voices across the value chain, the panel will address:
- Trends shaping investment and deal flow in vaccines
- The role of flexible manufacturing and platform tech in pandemic preparedness
- How innovators and CDMOs can co-develop agile, scalable solutions
- Avoiding common CMC and process development disconnects
- Creating alignment between product vision, patient need, and production capacity
Ideal for: Executives, BD leaders, CDMOs, policy makers, and global health stakeholders.
Day 1 - Tuesday 14th October @ 11:30
Working Group 3: Making Vaccines Real: Aligning Science, Capital, and Supply Chains for Global Impact
This high-level discussion focuses on how to translate great science into usable vaccines - on time and at scale. With voices across the value chain, the panel will address:
- Trends shaping investment and deal flow in vaccines
- The role of flexible manufacturing and platform tech in pandemic preparedness
- How innovators and CDMOs can co-develop agile, scalable solutions
- Avoiding common CMC and process development disconnects
- Creating alignment between product vision, patient need, and production capacity
Ideal for: Executives, BD leaders, CDMOs, policy makers, and global health stakeholders.
Day 1 - Tuesday 14th October @ 11:30
Working Group 3: Making Vaccines Real: Aligning Science, Capital, and Supply Chains for Global Impact
This high-level discussion focuses on how to translate great science into usable vaccines - on time and at scale. With voices across the value chain, the panel will address:
- Trends shaping investment and deal flow in vaccines
- The role of flexible manufacturing and platform tech in pandemic preparedness
- How innovators and CDMOs can co-develop agile, scalable solutions
- Avoiding common CMC and process development disconnects
- Creating alignment between product vision, patient need, and production capacity
Ideal for: Executives, BD leaders, CDMOs, policy makers, and global health stakeholders.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events